Belvedere Trading LLC Applied Therapeutics Inc. Call Options Transaction History

Belvedere Trading LLC

  • $82.2 Billion
  • Q4 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Nov 01, 2024
BUY
$4.04 - $6.37 $79,992 - $126,126
19,800 New
19,800 $92,000
Q2 2024

Aug 09, 2024
BUY
$4.04 - $6.37 $12,120 - $19,110
3,000 Added 17.86%
19,800 $92,000
Q1 2024

May 09, 2024
BUY
$2.25 - $7.4 $32,175 - $105,820
14,300 Added 572.0%
16,800 $114,000
Q4 2023

Feb 13, 2024
BUY
$1.84 - $3.35 $4,600 - $8,375
2,500 New
2,500 $8,000
Q2 2023

Aug 08, 2023
BUY
$0.77 - $1.8 $7,854 - $18,360
10,200 New
10,200 $13,000

Others Institutions Holding APLT

# of Institutions
139
Shares Held
111M
Call Options Held
1.68M
Put Options Held
1.91M
View Full List

About Applied Therapeutics Inc.

APLT Quotes by TradingView
  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $28.3M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email